Intercept Pharmaceuticals' Ocaliva may cause death

The Food and Drug Administration warned that Intercept Pharmaceuticals Inc.'s (Nasdaq: ICPT) Ocalivia may cause liver damage and possible death. Shares of the biopharmaceutical collapsed $24.42 to close at $73.70.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.